nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0289	0.0358	CbGbCtD
Proguanil—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0281	0.0348	CbGbCtD
Proguanil—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0264	0.0327	CbGbCtD
Proguanil—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.026	0.0321	CbGbCtD
Proguanil—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0244	0.0302	CbGbCtD
Proguanil—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0244	0.0302	CbGbCtD
Proguanil—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0239	0.0296	CbGbCtD
Proguanil—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0239	0.0296	CbGbCtD
Proguanil—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0234	0.029	CbGbCtD
Proguanil—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0221	0.0273	CbGbCtD
Proguanil—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.022	0.0272	CbGbCtD
Proguanil—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.022	0.0272	CbGbCtD
Proguanil—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0214	0.0265	CbGbCtD
Proguanil—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0206	0.0256	CbGbCtD
Proguanil—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0201	0.0249	CbGbCtD
Proguanil—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0201	0.0249	CbGbCtD
Proguanil—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.02	0.0248	CbGbCtD
Proguanil—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0199	0.0246	CbGbCtD
Proguanil—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0199	0.0246	CbGbCtD
Proguanil—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0185	0.0229	CbGbCtD
Proguanil—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0182	0.0225	CbGbCtD
Proguanil—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0182	0.0225	CbGbCtD
Proguanil—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0181	0.0224	CbGbCtD
Proguanil—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0181	0.0224	CbGbCtD
Proguanil—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0174	0.0215	CbGbCtD
Proguanil—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0172	0.0213	CbGbCtD
Proguanil—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0167	0.0207	CbGbCtD
Proguanil—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0167	0.0206	CbGbCtD
Proguanil—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0157	0.0194	CbGbCtD
Proguanil—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0152	0.0189	CbGbCtD
Proguanil—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0151	0.0187	CbGbCtD
Proguanil—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0151	0.0187	CbGbCtD
Proguanil—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0144	0.0179	CbGbCtD
Proguanil—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0138	0.0171	CbGbCtD
Proguanil—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0138	0.0171	CbGbCtD
Proguanil—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0136	0.0168	CbGbCtD
Proguanil—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0128	0.0158	CbGbCtD
Proguanil—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0128	0.0158	CbGbCtD
Proguanil—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0116	0.0143	CbGbCtD
Proguanil—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0116	0.0143	CbGbCtD
Proguanil—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00998	0.0124	CbGbCtD
Proguanil—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00969	0.012	CbGbCtD
Proguanil—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00876	0.0109	CbGbCtD
Proguanil—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00876	0.0109	CbGbCtD
Proguanil—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0084	0.0104	CbGbCtD
Proguanil—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00157	0.056	CbGeAlD
Proguanil—DHFR—retina—acquired immunodeficiency syndrome	0.00151	0.0539	CbGeAlD
Proguanil—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00128	0.0457	CbGeAlD
Proguanil—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00122	0.0434	CbGeAlD
Proguanil—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00116	0.0411	CbGeAlD
Proguanil—DHFR—lymphoid tissue—acquired immunodeficiency syndrome	0.00108	0.0383	CbGeAlD
Proguanil—DHFR—digestive system—acquired immunodeficiency syndrome	0.00106	0.0378	CbGeAlD
Proguanil—DHFR—blood—acquired immunodeficiency syndrome	0.00101	0.0361	CbGeAlD
Proguanil—DHFR—bone marrow—acquired immunodeficiency syndrome	0.00098	0.0349	CbGeAlD
Proguanil—DHFR—spinal cord—acquired immunodeficiency syndrome	0.000976	0.0347	CbGeAlD
Proguanil—DHFR—vagina—acquired immunodeficiency syndrome	0.000939	0.0334	CbGeAlD
Proguanil—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00093	0.0331	CbGeAlD
Proguanil—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00092	0.0056	CcSEcCtD
Proguanil—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000915	0.0326	CbGeAlD
Proguanil—DHFR—lung—acquired immunodeficiency syndrome	0.000888	0.0316	CbGeAlD
Proguanil—Stomatitis—Zidovudine—acquired immunodeficiency syndrome	0.000842	0.00512	CcSEcCtD
Proguanil—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000835	0.00508	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.00083	0.00505	CcSEcCtD
Proguanil—DHFR—nervous system—acquired immunodeficiency syndrome	0.000822	0.0293	CbGeAlD
Proguanil—Hepatobiliary disease—Zidovudine—acquired immunodeficiency syndrome	0.000817	0.00497	CcSEcCtD
Proguanil—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000808	0.00492	CcSEcCtD
Proguanil—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000808	0.00492	CcSEcCtD
Proguanil—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.000804	0.00489	CcSEcCtD
Proguanil—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.000794	0.00483	CcSEcCtD
Proguanil—DHFR—central nervous system—acquired immunodeficiency syndrome	0.000792	0.0282	CbGeAlD
Proguanil—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000785	0.00478	CcSEcCtD
Proguanil—Mental disorder—Stavudine—acquired immunodeficiency syndrome	0.000782	0.00476	CcSEcCtD
Proguanil—Malnutrition—Nelfinavir—acquired immunodeficiency syndrome	0.000779	0.00474	CcSEcCtD
Proguanil—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.000779	0.00474	CcSEcCtD
Proguanil—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000778	0.00473	CcSEcCtD
Proguanil—Malnutrition—Stavudine—acquired immunodeficiency syndrome	0.000777	0.00473	CcSEcCtD
Proguanil—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000773	0.00471	CcSEcCtD
Proguanil—Malnutrition—Abacavir—acquired immunodeficiency syndrome	0.000765	0.00466	CcSEcCtD
Proguanil—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.000763	0.00465	CcSEcCtD
Proguanil—Hepatobiliary disease—Indinavir—acquired immunodeficiency syndrome	0.00076	0.00462	CcSEcCtD
Proguanil—Hepatobiliary disease—Efavirenz—acquired immunodeficiency syndrome	0.000718	0.00437	CcSEcCtD
Proguanil—Stomatitis—Delavirdine—acquired immunodeficiency syndrome	0.000708	0.00431	CcSEcCtD
Proguanil—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000699	0.00425	CcSEcCtD
Proguanil—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.000696	0.00424	CcSEcCtD
Proguanil—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.000696	0.00423	CcSEcCtD
Proguanil—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000691	0.00421	CcSEcCtD
Proguanil—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000688	0.00419	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00068	0.00414	CcSEcCtD
Proguanil—Mental disorder—Zidovudine—acquired immunodeficiency syndrome	0.000679	0.00413	CcSEcCtD
Proguanil—Hallucination—Efavirenz—acquired immunodeficiency syndrome	0.000678	0.00413	CcSEcCtD
Proguanil—Cough—Stavudine—acquired immunodeficiency syndrome	0.000678	0.00412	CcSEcCtD
Proguanil—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000675	0.00411	CcSEcCtD
Proguanil—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.000675	0.00411	CcSEcCtD
Proguanil—Cough—Abacavir—acquired immunodeficiency syndrome	0.000668	0.00406	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000659	0.00401	CcSEcCtD
Proguanil—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000657	0.004	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000657	0.004	CcSEcCtD
Proguanil—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000655	0.00399	CcSEcCtD
Proguanil—Stomatitis—Ritonavir—acquired immunodeficiency syndrome	0.000655	0.00398	CcSEcCtD
Proguanil—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000651	0.00396	CcSEcCtD
Proguanil—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.000649	0.00395	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000647	0.00394	CcSEcCtD
Proguanil—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000644	0.00392	CcSEcCtD
Proguanil—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000638	0.00388	CcSEcCtD
Proguanil—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000635	0.00386	CcSEcCtD
Proguanil—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000635	0.00386	CcSEcCtD
Proguanil—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000633	0.00385	CcSEcCtD
Proguanil—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.00063	0.00383	CcSEcCtD
Proguanil—DHFR—brain—acquired immunodeficiency syndrome	0.000628	0.0224	CbGeAlD
Proguanil—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000628	0.00382	CcSEcCtD
Proguanil—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000626	0.00381	CcSEcCtD
Proguanil—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000622	0.00378	CcSEcCtD
Proguanil—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000618	0.00376	CcSEcCtD
Proguanil—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000616	0.00375	CcSEcCtD
Proguanil—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000615	0.00375	CcSEcCtD
Proguanil—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000614	0.00374	CcSEcCtD
Proguanil—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000612	0.00373	CcSEcCtD
Proguanil—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000611	0.00372	CcSEcCtD
Proguanil—DHFR—lymph node—acquired immunodeficiency syndrome	0.000607	0.0216	CbGeAlD
Proguanil—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000607	0.00369	CcSEcCtD
Proguanil—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000606	0.00369	CcSEcCtD
Proguanil—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000605	0.0215	CbGeAlD
Proguanil—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000604	0.00368	CcSEcCtD
Proguanil—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000601	0.00366	CcSEcCtD
Proguanil—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.0006	0.00365	CcSEcCtD
Proguanil—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000597	0.00363	CcSEcCtD
Proguanil—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000595	0.00362	CcSEcCtD
Proguanil—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000593	0.00361	CcSEcCtD
Proguanil—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000593	0.00361	CcSEcCtD
Proguanil—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000589	0.00358	CcSEcCtD
Proguanil—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000583	0.00355	CcSEcCtD
Proguanil—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000577	0.00351	CcSEcCtD
Proguanil—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000577	0.00351	CcSEcCtD
Proguanil—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000577	0.00351	CcSEcCtD
Proguanil—CYP2C19—blood—acquired immunodeficiency syndrome	0.000576	0.0205	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000571	0.00347	CcSEcCtD
Proguanil—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000571	0.00347	CcSEcCtD
Proguanil—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000568	0.00345	CcSEcCtD
Proguanil—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000568	0.00345	CcSEcCtD
Proguanil—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000567	0.00345	CcSEcCtD
Proguanil—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000553	0.00336	CcSEcCtD
Proguanil—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000551	0.00335	CcSEcCtD
Proguanil—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000549	0.00334	CcSEcCtD
Proguanil—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000548	0.00333	CcSEcCtD
Proguanil—Cough—Indinavir—acquired immunodeficiency syndrome	0.000548	0.00333	CcSEcCtD
Proguanil—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000547	0.00333	CcSEcCtD
Proguanil—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000545	0.00331	CcSEcCtD
Proguanil—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000543	0.00331	CcSEcCtD
Proguanil—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000543	0.0033	CcSEcCtD
Proguanil—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00054	0.00329	CcSEcCtD
Proguanil—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000539	0.00328	CcSEcCtD
Proguanil—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000537	0.00327	CcSEcCtD
Proguanil—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000535	0.00326	CcSEcCtD
Proguanil—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000534	0.019	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000531	0.00323	CcSEcCtD
Proguanil—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00321	CcSEcCtD
Proguanil—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000525	0.0032	CcSEcCtD
Proguanil—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000525	0.00319	CcSEcCtD
Proguanil—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000524	0.00319	CcSEcCtD
Proguanil—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000523	0.00318	CcSEcCtD
Proguanil—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00052	0.00316	CcSEcCtD
Proguanil—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000519	0.00316	CcSEcCtD
Proguanil—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000519	0.00316	CcSEcCtD
Proguanil—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000518	0.00315	CcSEcCtD
Proguanil—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000518	0.00315	CcSEcCtD
Proguanil—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000511	0.00311	CcSEcCtD
Proguanil—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000509	0.0031	CcSEcCtD
Proguanil—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00309	CcSEcCtD
Proguanil—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000505	0.00307	CcSEcCtD
Proguanil—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000505	0.00307	CcSEcCtD
Proguanil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000505	0.00307	CcSEcCtD
Proguanil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000504	0.00307	CcSEcCtD
Proguanil—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000503	0.00306	CcSEcCtD
Proguanil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000503	0.00306	CcSEcCtD
Proguanil—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000502	0.00306	CcSEcCtD
Proguanil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000502	0.00305	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000501	0.00305	CcSEcCtD
Proguanil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000501	0.00305	CcSEcCtD
Proguanil—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000501	0.00305	CcSEcCtD
Proguanil—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.0005	0.00304	CcSEcCtD
Proguanil—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.0005	0.00304	CcSEcCtD
Proguanil—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000499	0.00304	CcSEcCtD
Proguanil—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000498	0.00303	CcSEcCtD
Proguanil—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000495	0.00301	CcSEcCtD
Proguanil—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000494	0.0176	CbGeAlD
Proguanil—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000494	0.003	CcSEcCtD
Proguanil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000494	0.003	CcSEcCtD
Proguanil—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000488	0.00297	CcSEcCtD
Proguanil—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000482	0.00293	CcSEcCtD
Proguanil—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000482	0.00293	CcSEcCtD
Proguanil—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000479	0.00291	CcSEcCtD
Proguanil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000476	0.00289	CcSEcCtD
Proguanil—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000476	0.00289	CcSEcCtD
Proguanil—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00289	CcSEcCtD
Proguanil—CYP1A2—blood—acquired immunodeficiency syndrome	0.00047	0.0168	CbGeAlD
Proguanil—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00047	0.00286	CcSEcCtD
Proguanil—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000469	0.0167	CbGeAlD
Proguanil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000464	0.00282	CcSEcCtD
Proguanil—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000461	0.00281	CcSEcCtD
Proguanil—Rash—Didanosine—acquired immunodeficiency syndrome	0.00046	0.0028	CcSEcCtD
Proguanil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00046	0.0028	CcSEcCtD
Proguanil—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000458	0.00279	CcSEcCtD
Proguanil—Headache—Didanosine—acquired immunodeficiency syndrome	0.000457	0.00278	CcSEcCtD
Proguanil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00045	0.00274	CcSEcCtD
Proguanil—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00045	0.00274	CcSEcCtD
Proguanil—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00045	0.016	CbGeAlD
Proguanil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000449	0.00273	CcSEcCtD
Proguanil—CYP2C9—blood—acquired immunodeficiency syndrome	0.000447	0.0159	CbGeAlD
Proguanil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000445	0.00271	CcSEcCtD
Proguanil—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000444	0.0158	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000444	0.0027	CcSEcCtD
Proguanil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000442	0.00269	CcSEcCtD
Proguanil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000441	0.00269	CcSEcCtD
Proguanil—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000441	0.00268	CcSEcCtD
Proguanil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00265	CcSEcCtD
Proguanil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00265	CcSEcCtD
Proguanil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00265	CcSEcCtD
Proguanil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000434	0.00264	CcSEcCtD
Proguanil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000434	0.00264	CcSEcCtD
Proguanil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000427	0.0026	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.0026	CcSEcCtD
Proguanil—CYP2E1—blood—acquired immunodeficiency syndrome	0.000423	0.0151	CbGeAlD
Proguanil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000421	0.00256	CcSEcCtD
Proguanil—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00042	0.00256	CcSEcCtD
Proguanil—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00256	CcSEcCtD
Proguanil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000419	0.00255	CcSEcCtD
Proguanil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000418	0.00254	CcSEcCtD
Proguanil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000417	0.00254	CcSEcCtD
Proguanil—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000416	0.00253	CcSEcCtD
Proguanil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00252	CcSEcCtD
Proguanil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00252	CcSEcCtD
Proguanil—CYP1A2—lung—acquired immunodeficiency syndrome	0.000412	0.0147	CbGeAlD
Proguanil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000411	0.0025	CcSEcCtD
Proguanil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.00248	CcSEcCtD
Proguanil—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000408	0.0145	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00248	CcSEcCtD
Proguanil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000405	0.00246	CcSEcCtD
Proguanil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000405	0.00246	CcSEcCtD
Proguanil—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00246	CcSEcCtD
Proguanil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000404	0.00246	CcSEcCtD
Proguanil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000403	0.00245	CcSEcCtD
Proguanil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000403	0.00245	CcSEcCtD
Proguanil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.00244	CcSEcCtD
Proguanil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.0004	0.00244	CcSEcCtD
Proguanil—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.0004	0.00244	CcSEcCtD
Proguanil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.0004	0.00243	CcSEcCtD
Proguanil—Rash—Stavudine—acquired immunodeficiency syndrome	0.0004	0.00243	CcSEcCtD
Proguanil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000399	0.00243	CcSEcCtD
Proguanil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000398	0.00242	CcSEcCtD
Proguanil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000397	0.00242	CcSEcCtD
Proguanil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000397	0.00242	CcSEcCtD
Proguanil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.00241	CcSEcCtD
Proguanil—Rash—Abacavir—acquired immunodeficiency syndrome	0.000394	0.0024	CcSEcCtD
Proguanil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000393	0.00239	CcSEcCtD
Proguanil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.00239	CcSEcCtD
Proguanil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000391	0.00238	CcSEcCtD
Proguanil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00039	0.00237	CcSEcCtD
Proguanil—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.00235	CcSEcCtD
Proguanil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00233	CcSEcCtD
Proguanil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00233	CcSEcCtD
Proguanil—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000382	0.00232	CcSEcCtD
Proguanil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.0023	CcSEcCtD
Proguanil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000378	0.0023	CcSEcCtD
Proguanil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00229	CcSEcCtD
Proguanil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000376	0.00229	CcSEcCtD
Proguanil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.00228	CcSEcCtD
Proguanil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.00227	CcSEcCtD
Proguanil—CYP2E1—lung—acquired immunodeficiency syndrome	0.000371	0.0132	CbGeAlD
Proguanil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000371	0.00226	CcSEcCtD
Proguanil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00037	0.00225	CcSEcCtD
Proguanil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.00223	CcSEcCtD
Proguanil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.00223	CcSEcCtD
Proguanil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00218	CcSEcCtD
Proguanil—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000357	0.0127	CbGeAlD
Proguanil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.00217	CcSEcCtD
Proguanil—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000352	0.0125	CbGeAlD
Proguanil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00213	CcSEcCtD
Proguanil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00035	0.00213	CcSEcCtD
Proguanil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00213	CcSEcCtD
Proguanil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00211	CcSEcCtD
Proguanil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00211	CcSEcCtD
Proguanil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000345	0.0021	CcSEcCtD
Proguanil—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000344	0.0122	CbGeAlD
Proguanil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000342	0.00208	CcSEcCtD
Proguanil—CYP3A4—blood—acquired immunodeficiency syndrome	0.000341	0.0121	CbGeAlD
Proguanil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00207	CcSEcCtD
Proguanil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00206	CcSEcCtD
Proguanil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00206	CcSEcCtD
Proguanil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00205	CcSEcCtD
Proguanil—CYP2D6—blood—acquired immunodeficiency syndrome	0.000335	0.0119	CbGeAlD
Proguanil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.00202	CcSEcCtD
Proguanil—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000331	0.0118	CbGeAlD
Proguanil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000327	0.00199	CcSEcCtD
Proguanil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00198	CcSEcCtD
Proguanil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00198	CcSEcCtD
Proguanil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000326	0.00198	CcSEcCtD
Proguanil—Rash—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00197	CcSEcCtD
Proguanil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00196	CcSEcCtD
Proguanil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00196	CcSEcCtD
Proguanil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000321	0.00195	CcSEcCtD
Proguanil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00193	CcSEcCtD
Proguanil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00189	CcSEcCtD
Proguanil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00189	CcSEcCtD
Proguanil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000308	0.00187	CcSEcCtD
Proguanil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00186	CcSEcCtD
Proguanil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00186	CcSEcCtD
Proguanil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000304	0.00185	CcSEcCtD
Proguanil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.00185	CcSEcCtD
Proguanil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.00179	CcSEcCtD
Proguanil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00178	CcSEcCtD
Proguanil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00178	CcSEcCtD
Proguanil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00178	CcSEcCtD
Proguanil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.00177	CcSEcCtD
Proguanil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00175	CcSEcCtD
Proguanil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00172	CcSEcCtD
Proguanil—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000276	0.00984	CbGeAlD
Proguanil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00167	CcSEcCtD
Proguanil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00166	CcSEcCtD
Proguanil—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000272	0.00969	CbGeAlD
Proguanil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00164	CcSEcCtD
Proguanil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00164	CcSEcCtD
Proguanil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00164	CcSEcCtD
Proguanil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.00163	CcSEcCtD
Proguanil—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000266	0.00948	CbGeAlD
Proguanil—CYP2E1—brain—acquired immunodeficiency syndrome	0.000263	0.00935	CbGeAlD
Proguanil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.0016	CcSEcCtD
Proguanil—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000262	0.00933	CbGeAlD
Proguanil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00158	CcSEcCtD
Proguanil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00158	CcSEcCtD
Proguanil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00157	CcSEcCtD
Proguanil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00155	CcSEcCtD
Proguanil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00152	CcSEcCtD
Proguanil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00151	CcSEcCtD
Proguanil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00151	CcSEcCtD
Proguanil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.0015	CcSEcCtD
Proguanil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00149	CcSEcCtD
Proguanil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00142	CcSEcCtD
Proguanil—CYP2D6—brain—acquired immunodeficiency syndrome	0.000208	0.0074	CbGeAlD
